MIOSTAT OPHTHALMIC LIQ 0.01% .01 %
CARBACHOL : .01 % · DIN 00042544 · ALCON CANADA INC
Health Canada status: MARKETED
What is MIOSTAT OPHTHALMIC LIQ 0.01%?
MIOSTAT OPHTHALMIC LIQ 0.01% .01 % contains CARBACHOL : .01 %. It is listed in the Health Canada Drug Product Database under DIN 00042544, held by ALCON CANADA INC, supplied as SOLUTION for INTRAOCULAR administration. Health Canada currently lists it as marketed, status dated 31-Dec-1980. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MIOSTAT OPHTHALMIC LIQ 0.01% used for?
MIOSTAT* (Carbachol Intraocular Solution, USP) is indicated for: • Intraocular use for obtaining miosis during surgery • Reduction of the intensity of intraocular pressure elevation in the first 24 hours after cataract surgery
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00042544 |
|---|---|
| Brand name | MIOSTAT OPHTHALMIC LIQ 0.01% |
| Generic / active ingredient | CARBACHOL : .01 % |
| Manufacturer | ALCON CANADA INC |
| Strength | .01 % |
| Dosage form | SOLUTION |
| Route of administration | INTRAOCULAR |
| Schedule | Prescription |
| ATC code | S01EB02 CARBACHOL |
| AHFS class | 52:40.20 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Dec-1980 |
| Original market date | 1980-12-31 00:00:00 |
How is it stored and handled?
Store at controlled room temperature (15 °C – 30 °C). Keep out of the reach and sight of children.
How is it supplied?
1.5 mL sterile glass vials packaged twelve to a carton.
What can be used instead?
Other Canadian products sharing ATC code S01EB02 CARBACHOL. 1 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CARBASTAT | 0.01 % | SOLUTION | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | CANCELLED POST MARKET | DIN 02195585 |
| ISOPTO CARBACHOL 1.5% | 1.5 % | LIQUID | ALCON CANADA INC | CANCELLED POST MARKET | DIN 00000655 |
| ISOPTO CARBACHOL 3% | 3 % | LIQUID | ALCON CANADA INC | CANCELLED POST MARKET | DIN 00000663 |
Who else supplies CARBACHOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CARBACHOL appears in 2 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.